Logo Image
Viewing
|Articles|December 14, 2010

Online tool shows co-payments for cyclosporine

Allergan has launched a new digital tool designed to help eye-care professionals determine patient co-payments when prescribing cyclosporine ophthalmic emulsion 0.05% (Restasis) to manage dry eye.

Irvine, CA-Allergan has launched a new digital tool designed to help eye-care professionals determine patient co-payments when prescribing cyclosporine ophthalmic emulsion 0.05% (Restasis) to manage dry eye.

Using a computer or smartphone, ophthalmologists and other eye-care professionals can enter a patient’s ZIP code and then obtain the average co-pay for the health plans that have the biggest enrollments in the geographic area.

The tool is available at www.restasiscopay.com.

Latest CME

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida
Video

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida

Carl J. Danzig, MD, FASRS

View more
When Mites Meet Their Match: Empowering Patients With Targeted Treatment for 𝘋𝘦𝘮𝘰𝘥𝘦𝘹 Blepharitis
Video

When Mites Meet Their Match: Empowering Patients With Targeted Treatment for 𝘋𝘦𝘮𝘰𝘥𝘦𝘹 Blepharitis

Mile Brujic, OD, FAAO; Pierce Kenworthy, OD, FAAO; Blair Lonsberry, MS, OD, MEd, FAAO

View more
The Presbyopia-Correcting and Toric IOL Playbook: Game-Changing Surgical Strategies to Enhance Patient Outcomes
Video

The Presbyopia-Correcting and Toric IOL Playbook: Game-Changing Surgical Strategies to Enhance Patient Outcomes

Uday Devgan, MD, FACS, FRCS

View more
(CME) The Truth About Presbyopia Drops: Evidence-Based Cases and Myth-Busting Insights
Video

(CME) The Truth About Presbyopia Drops: Evidence-Based Cases and Myth-Busting Insights

Damon Dierker, OD FAAO; Maria Pribis, OD

View more